ODE V
This article was originally published in The Rose Sheet
Executive Summary
Jonca Bull, MD, appointed deputy director, FDA Office of Drug Evaluation V, responsible for OTCs. Bull will report to ODE V Director Robert DeLap, MD/PhD, effective July 30. Debra Bowen, MD, left the position early this year to join McNeil Consumer Healthcare as VP-clinical research (1"The Rose Sheet" Jan. 3, p. 13). Currently acting director of the Office of Women's Health, Bull previously worked in the Office of the Commissioner as a special assistant and medical advisor to the deputy commissioner for operations. She joined FDA in 1994